The stratum corneum revisited

Journal of Dermatology

Volumn 23, Issue 11, 1996, Pages 756-768

  Elias, Peter M ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CERAMIDE; CYTOKINE; FILAGGRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

BILAYER MEMBRANE; CONFERENCE PAPER; DESMOSOME; DNA SYNTHESIS; EXOCYTOSIS; LAMELLAR BODY; LIPID COMPOSITION; LIPOGENESIS; PERMEABILITY BARRIER; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN LIPID INTERACTION; STRATUM CORNEUM;

EID: 0029826349     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02698.x     Document Type: Conference Paper

References (77)

1. Feingold KR: The regulation and role of epidermal lipid synthesis, Adv Lipid Res, 24: 57-79,1991.
2. Elias PM, Feingold KR: Lipids and the epidermal water barrier: Metabolism, regulation, and pathophysiology, Semin Dermatol, 11: 176-182, 1992.
3. Scheuplein RJ, Blank IH: Permeability of the skin, PhysiolRev, 51: 702-747, 1971.
4. Elias PM, Friend DS: The permeability barrier in mammalian epidermis,/ Cell Biol, 65: 180-191, 1975.
5. Elias PM: Epidermal lipids, barrier function, and desquamation,/ Invest Dermatol, 80: 44-49,1983.
6. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier, Adv Lipid Res, 24: 1-26,1991.
7. Ödland GP, Holbrook K: The lamellar granules of the epidermis, Curr Probl Dermatol, 9: 29-49,1987.
8. Landmann L: The epidermal permeability barrier, Anal Embryol, 178: 1-10,1988.
9. Menon GK, Feingold KR, Elias PM: The lamellar body secretory response to barrier disruption,/ Invest Dermatol, 98: 279-289,1992.
10. Wertz PW, Downing DT, Freinkel RK, Traczyk TN: Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis,/ Invest Dermatol, 83: 193-195,1984.
11. Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EHJr, Elias PM: Lamellar bodyenriched fractions from neonatal mice: Preparative techniques and partial characterization, J Invest Dermatol, 85: 289-295,1985.
12. Williams ML: Lipids in normal and pathological desquamation, Adv Lipid Res, 24: 211-252,1991.
13. Menon GK, Williams ML, Ghadially R, Elias PM: Lamellar bodies as delivery systems of hydrolytic enzymes: implications for normal cohesion and abnormal desquamation, Er]Dermatol, 126:337-345, 1992.
14. Fanasch M, Bassukas ID, Diepgen TL: Structural relationship between epidermal lipid lamellae, lamellar bodies and desmosomes in human epidermis: An ultrastructural study, BrJ Dermatol, 128: 1-9, 1993.
15. Elias PM, Williams ML, Maloney ME, et al: Stratum corneum lipids in disorders of unification: Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive Xlinked ichthyosis,/ Clin Invest, 74: 1414-1421, 1984.
16. Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration of the epidermal calcium grandient leads to enhanced lamellar body secretion,/ Invest Dermatol, 102: 789-795, 1994.
17. Madison KG, Swartzendniber DC, Wertz PW, Downing DT: Presence of intact intercellular lamellae in the upper layers of the stratum corenum, J Invest Dermatol, 88: 714-718,1987.
18. Hou SYE, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM: Membrane structures in normal and essential fatty acid deficient stratum corneum: Characterization by ruthenium tetroxide staining and X-ray diffraction,/ Invest Dermatol, 96: 215-223, 1991.
19. White SH, Mirejovsky D, King GI: Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum. An X-ray diffraction study, Biocliemistry, 27: 3725-3732,1988.
20. Swartzendruber DC, Wertz PW, Kitko DJ, Madison KG, Downing DT: Evidence that the corneocyte has a chemically-bound lipid envelope, J Invest Dermatol, 88: 709-713,1987.
21. Chang F, Swartzedrauber DC, Wertz PW, Squier CA: Covalently bound lipids in keratinizing epithelia, Biochim Biophys Acta, 1150: 98-102,1993.
22. Chapman SJ, Walsh A: Membrane-coating granules are acidic organelles which possess proton pumps, J Invest Dennatol, 93: 466-470, 1989.
23. Holleran WM, Takagi Y, Jackson SM, Tran HT, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function,/ Clin Invest, 91: 1656-1664,1993.
24. Holleran WM, Sidransky E, Menon GK, et al: Consequences of B-glucocerebrosidase deficiency in epidermis: Ultrastructure and permeability barrier alterations in Gaucher disease, J Clin Invest, 93: 1756-1764,1994.
25. Wertz PW, Cox PS, Squier CA, Downing DT: Lipids of epidermis and keratinized and non-keratinized oral epithelia, Comp Biochem Physiol [B], 83: 529-531,1986.
26. Wertz PW, Kremer M, Squier SM: Comparison of lipids from epidermal and palatal stratum corneum,/ Invest Dennatol, 98: 375-378, 1992.
27. Elias PM, Menon GK, Grayson S, Brown BE, Rehfeld SJ: Avian sebokeratocytes and marine mammal lipokeratinocytes: Structural, lipid biochemical and functional considerations, Am] Anal, 180: 161-177,1987.
28. Chang F, Wertz PW, Squier CA: Comparison of glycosidase activities in epidermis, palatal epithelium, and buccal epithelium, Comp biochem physiol [B], 100: 137-139,1991.
29. Mao-Qiang M, Feingold KR, Jain M, Elias PM: Extracellular processing of phospholipids to free fatty acids is required for permeability barrier homeostasisJL/p/rf/te, 36: 192-193,1995.
30. Mao-Qiang M, Jain M, Feingold KR, Elias PM: Secretory phospholipase A.J activity is required for permeability barrier homeostasis, J Invest Dermalol, 106: 57-63,1996.
31. Lampe MA, Burlingame AL, WhitneyJ, et al: Human stratum corneum lipids: Characterization and regional variations,/ Lipid Res, 24:120-150,1983.
32. Elias PM, Fritsch P, Epstein EH, Jr: Staphylococcal scalded skin syndrome: Clinical features, pathogenesis, and recent microbiological and biochemical developments, Arch Dermalol, 113: 207-219,1977.
33. Grubauer G, Feingold KR, Elias PM: Lipid content and lipid type as determinants of the epidermal permeability barrier,/ Lipid Res, 30: 89-96, 1989.
34. Elias PM, Brown BE: The mammalian cutaneous permeability barrier: Defective barrier function in essential fatty acid deficiency correlates with abnormal intercellular lipid deposition, Lab Invest, 39: 574-583,1978.
35. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: The signal for recovery of barrier structure and function,/ Lipid Res, 30: 323-333,1989.
36. Mao-Qiang M, Feingold KR, Elias PM: Exogenous lipids influence permeability barrier recovery in acetone treated murine skin, Arch Dermalol, 129: 728-738,1993.
37. Mao-Qiang M, Brown BE, Wu S, Feingold KR, Elias PM: Exogenous non-physiological vs physiological lipids: Divergent mechanisms for correction of permeability barrier dysfunction, Arch Dennatol, 131: 809-816,1995.
38. Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold KR: Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment, BrJ Dennatol, 133: 679-685, 1995.
39. Yardley HJ, Summerly R: Lipid composition and metabolism in normal and diseased epidermis, Pharmacol Ther, 13: 357-383,1981.
40. Ziboh VA, Chapkin RS: Metabolism and function of skin lipids, Prog Lipid Res, 27: 81-105, 1988.
41. TurleySD.AndersonJM.DietschyJM: Rates of sterol synthesis and uptake in the major organs of the rat in vivo, J Lipid Res 22: 551-569,1981.
42. Feingold KR, Wiley MH, Moser AH, et al: De novo sterologenesis in the intact primate,/ Lab Clin Med, 100: 405-410,1982.
43. Nicolaides N: Skin lipids, Science, 186: 19-26, 1974.
44. Feingold KR, Brown BE, Lear SR, Moser AH, Elias PM: Localization of de novo sterologenesis in mammalian skin,y Invest Dennatol, 81: 365-369,1983.
45. Monger DJ, Williams ML, Feingold KR, Brown BE, Elias PM: Localization of sites of lipid biosynthesis in mammalian epidemisj Lipid Res, 29: 603-612,1988.
46. Proksch E, Elias PM, Feingold KR: Localization and regulation of epidermal HMG CoA reductase activity by barrier requirements, Biochem Biophys Acta, 1083: 71-79,1991.
47. Holleran WM, Gao WN, Feingold KR, Elias PM: Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity, Arch Dermatol Res, 287: 254-258,1995.
48. Wu-Pong S, Elias PM, Feingold KR: Influence of altered serum cholesterol levels and fasting on cutaneous cholesterol synthesis, J Invest Dermatol, 102: 799-802,1994.
49. Ponec M, Havekes L, Kempenaar J, Vermeer BJ: Cultured human skin fibroblasts and keratinocytes: Differences in the regulation of cholesterol synthesis,/ Invest Dermatol, 81: 125-130,1983.
50. Mommaas-Kienhuis A-M, Grayson S, Wijsman MC, Vermeer BJ, Elias PM: LDL receptor expression on keratinocytes in normal and psoriatic epidermis, y Invest Dermatol, 89: 513-517, 1987.
51. Williams ML, Rutherford SL, Mommaas-Kienhuis AM, Grayson S, Vermeer BJ, Elias PM: Free sterol metabolism and low density lipoprotein receptor expression as differentiation markers in cultured human keratinocytes, y Cell Physiol, 1332: 428-440, 1987.
52. Ziboh VA, Miller CC: Essential fatty acid and polyunsturated fatty acid: Significance in cutaneous biology, Ann Rev Nutr, 10: 433-450,1990.
53. Menon GK, Feingold KR, Moser AH, Brown BE, Elias PM: De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements,/ Lipid Res, 26: 418-427,1985.
54. Grubauer G, Feingold KR, Elias PM: Relationship of epidermal lipogenesis to cutaneous barrier function, J Lipid Res, 28: 746-752,1987.
55. Holleran WM, Feingold KR, Mao-Qiang M, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by barrier requirements,/ Lipid Res, 32: 1151-1158,1991.
56. Proksch E, Feingold KR, Mao-Qiang M, Elias PM: Barrier function regulates epidermal DNA synthesis, J Clin Invest, 87:1668-1673,1991.
57. Feingold KR, Brown BE, Lear SR, Moser AH, Elias PM: Effect of essential fatty acid deficiency on cutaneous sterol synthesis, J Invest Dermatol, 87: 588-591,1986.
58. Proksch E, Elias PM, Feingold KR: Regulation of 3hydroxy-3-methyl-glutaryl-coenzyme A reductase activity in murine epidermis: Modulation of enzyme content and activation state by barrier requirements, J Clin Invest, 85: 874-882,1990.
59. Ottey K, Wood LC, Elias PM, Feingold KR: Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice,/ Invest Dermatol, 104: 401-405,1995.
60. Jackson SM, Wood LC, Lauer S, et 'al: Effect. of cutaneous permeability barrier disruption on HMG CoA reductase, LDL receptor and apoprotein E mRNA levels in the epidermis of hairless mice, J Lipid Res, 33:1307-1314,1992.
61. Choi S-J, Jackson SM, Elias PM, Feingold KR: The role of protein synthesis in permeability barrier homeostasis, in Ohkawara A (eds): The Biology of the Epidermis: Molecular and Functional Aspects, Elsevier Amsterdam, 1992, pp 11-19.
62. Holleran WM, Mao-Qiang M, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian barrier function: II. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation,/ Clin Invest, 88: 1338-1345, 1991.
63. Feingold KR, Mao-Qiang M, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier funcdon in mice,/ Clin Invest, 86: 1738-1745,1990.
64. Mao-Qiang M, Elias PM, Feingold KR: Fatty acids are required for epidermal permeability barrier function, JClin Invest, 92: 791-798,1993.
65. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Qiang M, Feingold KR: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis,/ Clin Invest, 89: 530-538,1992.
66. Menon GK, Grayson S, Elias PM: Ionic calcium reservoirs in mammalian epidermis: Ultrastructural localization with ion capture cytochemistry,/ Invest Dermatol, 84: 508-512, 1985.
67. Menon GK, Lee S, Elias PM, Feingold KR: Localiza-tion of calcium in murine epidermis following disruption and repair of the permeability barrier, Cell Tissue Res, 270: 503-512,1992.
68. Menon GK, Elias PM, Feingold KR: Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient, Br J Dermatol, 130: 139-147,1994.
69. Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion, J Invest Dermatol, 102: 789-795, 1994.
70. Kupper TS: Immune and inflammatory processes in cutaneous tissues: Mechanisms and speculations,/ Clin Invest, 86:1783,1990.
71. ) Hauser C, SauratJ-H, SchmittJA,Jaunin F, DayerJH: Interleukin-I is present in normal human epidermis, Jlmmunol, 136: 3317-3322,1986.
72. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice,/ Clin Invest, 90: 482-487,1992.
73. Tsai J-C, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM: Permeability barrier disruption alters the localization and expression of TNF-alpha protein in the epidermis, Arch Derm Res, 286: 242-248, 1994.
74. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C: Barrier function coordinately regulates epidermal IL-1 mRNA levels, Exp Dermatol, 3: 56-60,1994.
75. Nickoloff BJ, Naider Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin, J Am Acad Dermatol, 30: 535-546,1994.
76. Elias PM, Holleran WM, Feingold KR, Menon GK, Ghadially R, Williams ML: Normal mechanisms and pathophysiology of epidermal permeability barrier homeostasis, Curr Opin in Dematol, 231-237,1993.
77. Ghadially R, Halkier-Sorenson L, Elias PM: Effects of petrolatum on stratum corneum structure and function,/ Am Acad Dermatol, 26: 387-396,1992.